Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$17.18 USD
-0.75 (-4.18%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $17.20 +0.02 (0.12%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Brokerage Reports
0 items in cart
Phibro Animal Health Corporation [PAHC]
Reports for Purchase
Showing records 1 - 20 ( 252 total )
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Solid 2Q24; Maintains Outlook with Lower Feed Prices Supportive
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B